A detailed history of Geode Capital Management, LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,622,575 shares of PSTX stock, worth $4.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,622,575
Previous 1,563,360 3.79%
Holding current value
$4.71 Million
Previous $4.99 Million 5.01%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.0 - $3.46 $118,430 - $204,883
59,215 Added 3.79%
1,622,575 $4.74 Million
Q1 2024

May 13, 2024

BUY
$2.76 - $4.13 $111,241 - $166,459
40,305 Added 2.65%
1,563,360 $4.99 Million
Q4 2023

Feb 13, 2024

BUY
$1.83 - $3.51 $191,670 - $367,630
104,738 Added 7.38%
1,523,055 $5.12 Million
Q3 2023

Nov 13, 2023

BUY
$1.62 - $2.79 $313,875 - $540,562
193,750 Added 15.82%
1,418,317 $3.38 Million
Q2 2023

Aug 11, 2023

BUY
$1.66 - $3.4 $1.19 Million - $2.44 Million
718,477 Added 141.97%
1,224,567 $2.16 Million
Q1 2023

May 15, 2023

BUY
$3.08 - $8.73 $45,023 - $127,615
14,618 Added 2.97%
506,090 $1.56 Million
Q4 2022

Feb 13, 2023

BUY
$3.33 - $6.38 $121,278 - $232,359
36,420 Added 8.0%
491,472 $2.6 Million
Q3 2022

Nov 14, 2022

BUY
$2.43 - $4.51 $467,947 - $868,495
192,571 Added 73.37%
455,052 $1.61 Million
Q2 2022

Aug 12, 2022

SELL
$1.87 - $5.0 $449,830 - $1.2 Million
-240,551 Reduced 47.82%
262,481 $677,000
Q1 2022

May 13, 2022

BUY
$3.22 - $7.04 $40,034 - $87,528
12,433 Added 2.53%
503,032 $2.25 Million
Q4 2021

Feb 11, 2022

BUY
$6.23 - $7.6 $709,285 - $865,260
113,850 Added 30.22%
490,599 $3.34 Million
Q3 2021

Nov 12, 2021

BUY
$7.09 - $10.71 $1,453 - $2,195
205 Added 0.05%
376,749 $2.75 Million
Q2 2021

Aug 13, 2021

SELL
$7.96 - $10.07 $208,942 - $264,327
-26,249 Reduced 6.52%
376,544 $3.77 Million
Q1 2021

May 12, 2021

BUY
$8.51 - $11.91 $1.62 Million - $2.26 Million
189,886 Added 89.19%
402,793 $3.85 Million
Q4 2020

Feb 12, 2021

BUY
$8.29 - $11.7 $199,515 - $281,583
24,067 Added 12.74%
212,907 $2.34 Million
Q3 2020

Nov 13, 2020

BUY
$8.09 - $16.25 $1.53 Million - $3.07 Million
188,840 New
188,840 $1.68 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $249M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.